PMV Pharmaceuticals, Inc. - 8-K Filing
PMV Pharmaceuticals reports Q3 2026 net loss of $34.4 million and announces $50 million public offering closing. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $PMVP
Read the full article at SEC EDGAR
Part of the story Noble Corp plc - 8-K Filing (63 articles)